The All India Organization of Chemists and Druggists (AIOCD) has asked all the members of the organization to make available all medicines to all needy patients of C-19, and do not indulge in hoarding any stock under any circumstances.
In a letter to all members of states and districts regarding shortage of remdesivir in the country, the AIOCD directed all its members to make available all medicine to all needy patients.
Also read more article on AIOCD, click here
AIOCD president J S Shinde said, “This is high time to support the patients as Jan Swasthy Rakshak of the country by serving humanity. Since the situation is very critical and because of shortages of medicines, our fraternity is getting blamed.”
“AIOCD is always giving instruction to all 9.40 lakh members of the country every time to make availability all medicines on price as fixed by the government and stay away from hoarding of any of the medicines,” stated AIOCD general secretary Rajiv Singhal.
To read more articles on Remdesivir, click here
Remdesivir was approved by the Food and Drug Administration for emergency use to treat C-19 in around 50 countries. Remdesivir was originally developed to treat hepatitis C, and was subsequently investigated for ebola virus disease and Marburg virus infections before being studied as a post-infection treatment for C-19.
The Drug Controller General of India (DCGI) in a letter dated April 7, 2021 had asked state drug regulators to ensure availability of remdesivir and prevent from hoarding and black marketing.
“States such as Maharashtra (Mumbai, Thane), Gujarat (Ahmedabad, Surat, Rajkot) and Madhya Pradesh (Indore, Bhopal, Gwalior) are facing shortage of remdesivir injection,” the letter stated.
DCGI also requested to initiate immediate action to ensure supply of remdesivir injection to public and private hospitals and to instruct the enforcement staff to monitor the situation and keep strict vigil to ensure availability of remdesivir.
Subscribe for daily free updates on Telegram
For daily free updates on WhatsApp, click here